LCZ696 in Advanced LV Hypertrophy and HFpEF

NCT03928158 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

OTHER_GOV

Sponsor class

Conditions

Heart Failure
Essential Hypertension

Interventions

DRUG: LCZ 696
DRUG: Valsartan

Sponsor

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation